US2005070191A1PendingUtilityA1

Method and article for treatment of inflammatory disease

Priority: May 27, 2003Filed: Oct 10, 2003Published: Mar 31, 2005
Est. expiryMay 27, 2023(expired)· nominal 20-yr term from priority
A61N 1/16A41D 13/1236A61B 2090/0436Y10T442/475
38
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of treatment of pain from inflammatory diseases such as arthritis is disclosed. The affected areas of the patient are shielded from high frequency electromagnetic radiation while permitting low frequency electromagnetic radiation to reach the affected areas. The method may be accomplished by applying a radiation-shielding textile for an extended period of time, either by fashioning a garment from the textile or using a sheet or cover, or fashioning a wrap. The radiation-shielding textile found to be suitable is a cloth woven of yarn consisting of a textile fibre, such as nylon, and from two to thirty-five percent by weight of electrically conductive filament, preferably stainless steel.

Claims

exact text as granted — not AI-modified
1 . A method of treatment of pain in a patient caused by an inflammatory disease comprising shielding the affected areas of the patient from high frequency electromagnetic radiation, while not shielding said affected areas from low frequency electromagnetic radiation, for a period of time sufficient to reduce the symptoms.  
     
     
         2 . The method of  claim 1  wherein said high frequency electromagnetic radiation has a frequency greater than about 1 megahertz.  
     
     
         3 . The method of  claim 2  wherein said low frequency electromagnetic radiation has a frequency less than about 1 megahertz.  
     
     
         4 . The method of  claim 1  wherein said shielding is accomplished by covering the affected area of said patient with a radiation-shielding textile for a period of time sufficient to reduce said symptoms.  
     
     
         5 . The method of  claim 4  wherein said radiation-shielding textile comprises between two and thirty-five percent by weight of a continuous system of electrically conductive fibers and the remainder of non-conductive fibers.  
     
     
         6 . The method of  claim 5  wherein said radiation-shielding textile is a woven cloth and said electrically conductive fibers are stainless steel fibers.  
     
     
         7 . The method of  claim 5  wherein said radiation-shielding textile is a woven cloth and said electrically conductive fibers are formed of a material selected from the group copper, silver or ceramic.  
     
     
         8 . The method of  claim 5  wherein said radiation-shielding textile is a knitted fabric and said electrically conductive fibers are stainless steel fibers.  
     
     
         9 . The method of  claim 5  wherein said radiation-shielding textile is a knitted fabric and said electrically conductive fibers are formed of a material selected from the group copper, silver or ceramic.  
     
     
         10 . The method of  claim 8  wherein said radiation-shielding textile comprises about thirteen percent by weight of a continuous system of electrically conductive fibers and the remainder of non-conductive fibers.  
     
     
         11 . A method of treatment of pain in a patient caused by an inflammatory disease comprising the steps of: 
 (i) providing an article of clothing configured to substantially cover the affected areas of the patient with a high-frequency electromagnetic radiation shielding cloth which does not shield low frequency electromagnetic radiation; and    (ii) said patient wearing said article of clothing whereby said affected areas of said patient are substantially covered by said cloth over a period of time sufficient to reduce said pain.    
     
     
         12 . The method of  claim 11  wherein radiation-shielding cloth comprises between two and thirty-five percent by weight of a continuous system of electrically conductive fibers and the remainder of non-conductive fibers.  
     
     
         13 . The method of  claim 12  wherein said electrically conductive fibers are formed of a material selected from the group copper, silver or ceramic.  
     
     
         14 . The method of  claim 11  wherein said radiation-shielding textile comprises about thirteen percent by weight of a continuous system of electrically conductive fibers and the remainder of non-conductive fibers  
     
     
         15 . The method of  claim 1  wherein said inflammatory disease is selected from the group Achilles tendinitis, Adhesive capsulitis, Ankylosing spondylitis, Anserine bursitis, Avascular necrosis, Bicipital tendinitis, Bursitis, Calcaneal bursitis, Calcium pyrophosphate dihydrate (CPPD), crystal deposition disease, Carpal tunnel syndrome, Chondrocalcinosis, Chondromalacia patellae, Costosternal syndrome, Degenerative joint disease, Dupuytren's contracture, Epicondylitis, Exercise-induced compartment syndrome, Fibromyalgia, Freiberg's disease, Gout, Hypertrophic osteoarthropathy, Impingement syndrome, Myofascial pain syndrome, Neuropathic arthropathy, Olecranon bursitis, Osgood-Schlatter's disease, Osteoarthritis, Osteochondromatosis, Osteoporosis, Paget's disease of bone, Patellofemoral pain syndrome, Plantar fasciitis, Polyarteritis nodosa, Polymyositis, Popliteal cysts, Posterior tibial tendinitis, Prepatellar bursitis, Psoriatic arthritis, Raynaud's phenomenon, Reflex sympathetic dystrophy syndrome, Retrocalcaneal bursitis, Rheumatoid arthritis, Rotator cuff tendinitis, Sacroiliitis, Scheuermann's osteochondritis, Scleroderma, Seronegative arthritis, Shoulder-hand syndrome, Spinal stenosis, Spondylolysis, Systemic lupus erythematosus (SLE), Tarsal tunnel syndrome, Tennis elbow, Traumatic arthritis and Trochanteric bursitis.  
     
     
         16 . The method of  claim 1  wherein said inflammatory disease is Achilles tendinitis.  
     
     
         17 . The method of  claim 1  wherein said inflammatory disease is Adhesive capsulitis.  
     
     
         18 . The method of  claim 1  wherein said inflammatory disease is Ankylosing spondylitis.  
     
     
         19 . The method of  claim 1  wherein said inflammatory disease is Anserine bursitis.  
     
     
         20 . The method of  claim 1  wherein said inflammatory disease is Avascular necrosis.  
     
     
         21 . The method of  claim 1  wherein said inflammatory disease is Bicipital tendinitis.  
     
     
         22 . The method of  claim 1  wherein said inflammatory disease is Bursitis.  
     
     
         23 . The method of  claim 1  wherein said inflammatory disease is Calcaneal bursitis.  
     
     
         24 . The method of  claim 1  wherein said inflammatory disease is Calcium pyrophosphate dihydrate (CPPD).  
     
     
         25 . The method of  claim 1  wherein said inflammatory disease is crystal deposition disease.  
     
     
         26 . The method of  claim 1  wherein said inflammatory disease is Carpal tunnel syndrome.  
     
     
         27 . The method of  claim 1  wherein said inflammatory disease is Chondrocalcinosis.  
     
     
         28 . The method of  claim 1  wherein said inflammatory disease is Chondromalacia patellae.  
     
     
         29 . The method of  claim 1  wherein said inflammatory disease is Costostemal syndrome.  
     
     
         30 . The method of  claim 1  wherein said inflammatory disease is Degenerative joint disease.  
     
     
         31 . The method of  claim 1  wherein said inflammatory disease is Dupuytren's contracture, Epicondylitis.  
     
     
         32 . The method of  claim 1  wherein said inflammatory disease is Exercise-induced compartment syndrome.  
     
     
         33 . The method of  claim 1  wherein said inflammatory disease is Fibromyalgia.  
     
     
         34 . The method of  claim 1  wherein said inflammatory disease is Freiberg's disease.  
     
     
         35 . The method of  claim 1  wherein said inflammatory disease is Gout.  
     
     
         36 . The method of  claim 1  wherein said inflammatory disease is Hypertrophic osteoarthropathy.  
     
     
         37 . The method of  claim 1  wherein said inflammatory disease is Impingement syndrome.  
     
     
         38 . The method of  claim 1  wherein said inflammatory disease is Myofascial pain syndrome.  
     
     
         39 . The method of  claim 1  wherein said inflammatory disease is Neuropathic arthropathy.  
     
     
         40 . The method of  claim 1  wherein said inflammatory disease is Olecranon bursitis.  
     
     
         41 . The method of  claim 1  wherein said inflammatory disease is Osgood-Schlatter's disease.  
     
     
         42 . The method of  claim 1  wherein said inflammatory disease is Osteoarthritis.  
     
     
         43 . The method of  claim 1  wherein said inflammatory disease is Osteochondromatosis.  
     
     
         44 . The method of  claim 1  wherein said inflammatory disease is Osteoporosis.  
     
     
         45 . The method of  claim 1  wherein said inflammatory disease is Paget's disease of bone.  
     
     
         46 . The method of  claim 1  wherein said inflammatory disease is Patellofemoral pain syndrome.  
     
     
         47 . The method of  claim 1  wherein said inflammatory disease is Plantar fasciitis.  
     
     
         48 . The method of  claim 1  wherein said inflammatory disease is Polyarteritis nodosa.  
     
     
         49 . The method of  claim 1  wherein said inflammatory disease is Polymyositis.  
     
     
         50 . The method of  claim 1  wherein said inflammatory disease is Popliteal cysts.  
     
     
         51 . The method of  claim 1  wherein said inflammatory disease is osterior tibial tendinitis.  
     
     
         52 . The method of  claim 1  wherein said inflammatory disease is Prepatellar bursitis.  
     
     
         53 . The method of  claim 1  wherein said inflammatory disease is Psoriatic arthritis.  
     
     
         54 . The method of  claim 1  wherein said inflammatory disease is Raynaud's phenomenon.  
     
     
         55 . The method of  claim 1  wherein said inflammatory disease is Reflex sympathetic dystrophy syndrome.  
     
     
         56 . The method of  claim 1  wherein said inflammatory disease is Retrocalcaneal bursitis.  
     
     
         57 . The method of  claim 1  wherein said inflammatory disease is Rheumatoid arthritis.  
     
     
         58 . The method of  claim 1  wherein said inflammatory disease is Rotator cuff tendinitis.  
     
     
         59 . The method of  claim 1  wherein said inflammatory disease is Sacroiliitis.  
     
     
         60 . The method of  claim 1  wherein said inflammatory disease is Scheuermann's osteochondritis.  
     
     
         61 . The method of  claim 1  wherein said inflammatory disease is Scleroderma.  
     
     
         62 . The method of  claim 1  wherein said inflammatory disease is Seronegative arthritis.  
     
     
         63 . The method of  claim 1  wherein said inflammatory disease is Shoulder-hand syndrome.  
     
     
         64 . The method of  claim 1  wherein said inflammatory disease is Spinal stenosis.  
     
     
         65 . The method of  claim 1  wherein said inflammatory disease is Spondylolysis.  
     
     
         66 . The method of  claim 1  wherein said inflammatory disease is Systemic lupus erythematosus (SLE).  
     
     
         67 . The method of  claim 1  wherein said inflammatory disease is Tarsal tunnel syndrome.  
     
     
         68 . The method of  claim 1  wherein said inflammatory disease is Tennis elbow.  
     
     
         69 . The method of  claim 1  wherein said inflammatory disease is Traumatic arthritis.  
     
     
         70 . The method of  claim 1  wherein said inflammatory disease is Trochanteric bursitis.

Join the waitlist — get patent alerts

Track US2005070191A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.